A Lesson in Internet Tantrums: Remember when people spent months yelling about American Eagle’s Sydney Sweeney campaign? Turns out, it got a 22% stock jump, new customer growth in every county in America, and was the most successful campaign in company history. ** So instead of backing away, they launched another one. **Which is a pretty direct way of saying, “
Bad Clients, Dumb Systems, and Other Recurring ChargesThe Cup Is the
New Combo****The Green JacketWasn’t the Only Status Symbol in AugustaThe Next Gold Rush Might Be…
Gene Editing?****Small Business OwnersAre Feeling the Squeeze.*Again.***And From Around the Web:**Wild Boars, Weed, and WebMD 2.0
Interested in reaching our audience of 100k+ Substack subscribers? YOUR BUSINESS can sponsor our newsletter. ➡️ Click here for more details.
*by *
April 15 gets all the attention.* Fair enough*. Folders appear. Passwords disappear. People swear they were organized this year. They were not.
**But for most business owners, the real taxes are not sitting on a government website. **They show up every week through bad systems, messy communication, slow decisions, admin overload, and all the other little leaks that quietly drain time, profit, and patience.
My latest piece breaks down 10 hidden taxes that make a business heavier than it needs to be, from decision fatigue and bad clients to founder guilt and complexity dressed up as growth.
👉 Go read it before one more “small issue” eats half your week.
McDonald’s is set to add energy drinks and crafted sodas to its menu, with the new beverages expected to start rolling out next month. That includes drinks like a Dirty Dr Pepper and Mango Pineapple Refresher, while the energy drink lineup is expected to hit in August. The move has been years in the making, including earlier beverage tests at the company’s short-lived CosMc’s concept, where McDonald’s tried everything from Sour Cherry Energy Burst to Blackberry Mint Green Tea.
The logic is not exactly mysterious. Drinks tend to carry higher margins than food, especially at a time when customers are trimming meal sizes but still seem perfectly willing to spend money on a caffeinated sugar experiment in a cup. McDonald’s plans to price the drinks below competitors like Starbucks, Dutch Bros, and Sonic, while franchisees have already spent thousands per restaurant on new equipment to make the drinks without slowing down service. The company also says operators were involved in figuring out how to prepare them efficiently.
The bigger backdrop here is that energy drinks and crafted sodas are booming. Consumers are looking beyond coffee and tea for their caffeine fix, while chains like Swig and Dutch Bros have shown just how profitable dirty sodas, fruity refreshers, and energy-based beverages can be. Taco Bell is already chasing the same play with dirty sodas and lemonades as part of its push to build a $5 billion beverage business by 2030. McDonald’s, meanwhile, learned from CosMc’s that customers were not exactly begging for turmeric or matcha lattes. So now it is going bigger on the drinks people actually want, while continuing its proud tradition of supporting a business model best described as highly efficient sugar distribution.
The takeaway?When margins get tight, smart operators look for the add-on category customers will gladly overpay for.
This year’s Masters drove one of the busiest private jet weeks Augusta has ever seen, with thousands of flights moving in and out of the city and nearby airports. NetJets alone projected more than 775 flights into and out of Augusta, up more than 35% from last year, while Flexjet estimated more than 350. The Masters has always pulled wealthy attendees, but what makes it especially attractive on the private jet calendar is the combination of a full week of events and a steady stream of high-end clients flying in and out the entire time.
That has turned Augusta into more than just a golf destination. It is now one of the key luxury aviation events of the year, right up there with Davos, the Super Bowl, Cannes, the Kentucky Derby, Monaco, and Art Basel. Competition for landing slots, parking, and terminal access has become so fierce that some operators have shifted to nearby airports in Thomson, Georgia, and Aiken, South Carolina just to manage the overflow. NetJets recently announced a new private terminal at Augusta Regional that will include 432,000 square feet of ramp space for jet parking, which tells you this is no longer a side note.
And because this crowd does not travel without being marketed to at all times, the jet companies are also battling on the ground. NetJets, Vista, and Wheels Up all hosted parties, luxury lounges, and pop-ups for Masters attendees, hoping to turn one week of golf into a pipeline for future customers. That makes sense when private jet demand is still elevated. Flights hit a record 3.9 million departures in 2025, up 34% from pre-Covid levels, helped along by airport delays and the general decline of patience among people with money.
The takeaway?When a high-end audience gathers in one place for long enough, convenience stops being a service and starts becoming its own luxury market.
➡️ Click through to see how a golf tournament quietly turned into a case study in luxury logistics.
…*keeps the acquirers away. * **Biopharma mergers and acquisitions are heating up. **In March alone, biopharma companies announced ten acquisitions worth about $31.5 billion, including two deals with more than $5 billion in upfront payments. Just a little over three months into 2026, total deal value has already passed 40% of its level for all of 2025. The big driver is the looming patent cliff, with roughly $300 billion in branded prescription drug revenue set to lose patent protection by the end of 2030. That includes giants like Merck’s Keytruda and Bristol Myers Squibb’s Eliquis, which helps explain why large pharma is leaning harder on outside innovation to refill late-stage pipelines.
Not all of these deals are trying to do the same thing. Some are straightforward attempts to plug future revenue gaps. Others are leapfrogs into crowded therapeutic markets. Gilead’s $7.8 billion acquisition of Arcellx, for example, adds a potentially safer CAR-T therapy for multiple myeloma that some expect could compete with Carvykti, which generated $1.9 billion in revenue last year. Other deals are broader bets on platform potential and new treatment categories. Eli Lilly’s $6.3 billion acquisition of Centessa Pharmaceuticals expands its pipeline into sleep disorders, while its earlier Verve Therapeutics deal marked one of big pharma’s first major bets that gene editing could scale beyond rare diseases and into cardiovascular disease.
This M&A cycle is doing more than setting prices for emerging platforms. It also looks like a structural bidding war that may stick around as patent pressure builds. In the near term, the clearest winners are companies with enough clinical validation to reduce development risk, especially those that can replace or improve on drugs nearing patent expiry.
The bigger opportunity may be in therapies that shift treatment from chronic management to one-time cures. Gene editing is the obvious example. Casgevy, the first CRISPR-based therapy, was approved in late 2023 as a functional cure for sickle cell disease. Intellia Therapeutics could become the first company to win approval for an in-vivo gene-editing treatment as early as next year, targeting hereditary angioedema. The next wave aims to push those one-time genetic fixes beyond rare diseases and into much larger conditions like cardiovascular disease. As the science keeps maturing, the companies making early bets on truly paradigm-shifting treatments may end up capturing the biggest long-term value.
The takeaway?When blockbuster drugs start nearing expiration, big pharma does not wait around. It starts shopping for the next revenue stream, and sometimes the next medical breakthrough with it.
with Matthew R. Meehan
Reuters reported that small business optimism fell to an 11-month low in March, while uncertainty kept climbing. Shocking, I know. Costs are up, visibility is lousy, and a lot of owners are getting squeezed by the same familiar mix: higher expenses, weaker confidence, and less room for error.
First, stop staring at revenue like it tells the whole story. It doesn’t. Look at margin. Look at what your jobs, products, or customers are actually leaving behind after the bills get paid. **Second, get honest about timing. **A lot of businesses are profitable on paper and still get punched in the mouth by cash flow. Third, do not wait until things feel desperate to look at funding. The later you wait, the worse the choices usually get.
The goal is not to panic. The goal is to catch the squeeze early, while you still have room to make smart decisions * instead of *expensive ones.
👉 And if you want to take a look at that before it turns into a bigger problem, talk to us here at Credit Banc. (** More info here**)
**Pork vs. Processor:**Wild boars were roaming Warsaw. Until alike this was completely normal city maintenance. We have officially entered the part of the timeline with no adult supervision.humanoid robot named Edward showed up and chased them offGrandma’s Gone Green:Recent reports show about15% of Americanshave used cannabis in the past month, and. Meanwhile, researchers are still trying to sort out whether it helps, hurts, or just makes everyone temporarily forget why they walked into the kitchen.adults over 60 are now the fastest-growing group of users**Science, as usual, would like a few more minutes.****Paging Dr. Chatbot:**About, often for quick answers before deciding whether a doctor was worth the trouble. About a third trust the results, a third do not,25% of U.S. adults recently turned to AI for health adviceand the last third are apparently just raw-dogging uncertainty with ChatGPT.
